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ttp://dx.doi.org/10.1016/j.ajpath.2012.11.005Bacterial infection plays a critical role in exacerbations of various lung diseases, including chronic
pulmonary obstructive disease (COPD) and asthma. Excessive lung inﬂammation is a prominent feature in
disease exacerbations, but the underlying mechanisms remain poorly understood. Cell surface glyco-
protein MUC18 (alias CD146 or melanoma cell adhesion molecule) has been shown to promote metastasis
in several tumors, including melanoma. We explored the function of MUC18 in lung inﬂammatory
responses to bacteria (eg, Mycoplasma pneumoniae) involved in lung disease exacerbations. MUC18
expression was increased in alveolar macrophages from lungs of COPD and asthma patients, compared
with normal healthy human subjects. Mouse alveolar macrophages also express MUC18. After M. pneu-
moniae lung infection, Muc18/ mice exhibited lower levels of the lung proinﬂammatory cytokines KC
and TNF-a and less neutrophil recruitment than Muc18þ/þ mice. Alveolar macrophages from Muc18/
mice produced less KC than those from Muc18þ/þ mice. In Muc18/ mouse alveolar macrophages,
adenovirus-mediated MUC18 gene transfer increased KC production. MUC18 ampliﬁed proinﬂammatory
responses in alveolar macrophages, in part through enhancing the activation of nuclear factor-kB
(NF-kB). Our results demonstrate, for the ﬁrst time, that MUC18 exerts a proinﬂammatory function during
lung bacterial infection. Up-regulated MUC18 expression in lungs (eg, in alveolar macrophages) of COPD
and asthma patients may contribute to excessive inﬂammation during disease exacerbations.
(Am J Pathol 2013, 182: 819e827; http://dx.doi.org/10.1016/j.ajpath.2012.11.005)Supported in part by NIH grants R01-HL088264 and R01-AI070175
(H.W.C.).
Q.W. and S.R.C. contributed equally to this work.Acute exacerbations of respiratory diseases such as chronic
obstructive pulmonary disease (COPD) and asthma are
associated with highmorbidity andmortality, and cost billions
of dollars for health care.1e6 Excessive pulmonary inﬂam-
mation is a core feature during acute exacerbations of COPD
and asthma. Although bacterial infection [eg, byMycoplasma
pneumoniae (Mp)] is recognized as one of the major triggers
in disease exacerbations and progression, the mechanisms
leading to an exaggerated lung inﬂammatory response to
bacteria remain poorly understood. A better understanding of
excessive lung inﬂammation during disease exacerbations can
likely provide promising approaches to more effective treat-
ments.7 In the present study we sought to reveal a potential
mechanism that exaggerates lung inﬂammatory responses to
bacterial infections, such as Mp infection, that are relevant to
COPD and asthma acute exacerbations.8e11stigative Pathology.
.MUC18, alias CD146 or melanoma cell adhesion molecule
(MCAM), is a 113-kDa transmembrane glycoprotein that has
been studied mostly in malignant melanoma.12e16 In the lung,
MUC18 expression is observed on endothelial and smooth
muscle cells in the airway wall.17 We recently showed that
MUC18 is signiﬁcantly increased in asthmatic airway
epithelial cells and is directly up-regulated by Th2 cytokine
IL-13 in primary bronchial epithelial cells.18 MUC18 up-
regulation was also reported in primary bronchial epithelial
cells from patients with COPD.19 Like airway epithelial cells,
lung leukocytes (eg, macrophages) also serve as the ﬁrst line
of host defense against invading pathogens. However, the
Wu et alexpression and function ofMUC18 in lungmacrophages have
not been investigated previously.
Wehypothesized that alveolarmacrophages indiseased lungs
increase MUC18 expression, which in turn ampliﬁes inﬂam-
matory responses to bacterial infection. To test our hypothesis,
we analyzed MUC18 expression in alveolar macrophages from
COPD and asthma patients. We then used theMuc18 knockout
mouse model to deﬁne the in vivo function of MUC18 in lung
inﬂammatory responses to bacteria.Moreover, we used primary
alveolar macrophage (pAM) cultures to dissect the role of
MUC18 in macrophages in regulating proinﬂammatory cyto-
kine production. Finally, we demonstrated that transcriptional
factor nuclear factor-kB (NF-kB) is involved in MUC18-
mediated production of proinﬂammatory cytokines.
Materials and Methods
Puriﬁcation of Human Alveolar Macrophages
To determine MUC18 expression in human pAMs, bron-
choalveolar lavage was performed in normal healthy donor
lungs obtained through the International Institute for the
Advancement of Medicine (Edison, NJ) and National Disease
Research Interchange (Philadelphia, PA), aswell as in patients
withmild tomoderate asthmaorCOPD throughbronchoscopy
performed at National Jewish Health. Alveolar macrophages
were puriﬁed by adhering BAL cells to cell culture plates for 2
hours at 37C in a 5% CO2eenriched atmosphere; cells were
then lysed in TRIzol reagent (Invitrogen; Life Technologies,
Carlsbad, CA) for RNA extraction. Real-time PCR was per-
formed for MUC18 mRNA expression.
The criteria and subject characteristics of the asthma and
COPD patients have been reported previously.20 The human
subject research protocols were approved by our institutional
review board, and all subjects provided written informed
consent.
MUC18 Immunostaining
To examine MUC18 protein expression in alveolar macro-
phages, immunostainingwas performed in parafﬁn-embedded
lung tissues of normal healthy human donors, patients with
moderate to severe COPD, and one patient who died of
asthma. Normal lungs were obtained through the International
Institute for the Advancement of Medicine and the National
Disease Research Interchange. COPD lungs were from the
NIH-National Heart, Lung, and Blood Institute Lung Tissue
ResearchConsortium.The fatally asthmatic lungwas obtained
at National Jewish Health, as described previously.18 Lung
tissue sections were stained with a rabbit anti-human MUC18
antibody or rabbit IgG control antibody (Epitomics, Burlin-
game, CA), as previously reported.18
To conﬁrm MUC18 expression by macrophages, immu-
noﬂuorescent double staining with MUC18 and F4/80 in
pAMs fromMuc18þ/þ andMuc18/mice was performed as
described previously.21e23820Animals
Our use of mice was approved by the Institutional Animal
Care and Use Committee of National Jewish Health.
Muc18þ/ mice on 129SvEvBr background were obtained
from Taconic Farms (Hudson, NY; distributed through
Lexicon Pharmaceuticals, The Woodlands, TX). Muc18þ/þ
and Muc18/ mice were generated by breeding Muc18þ/
mice in our biological resource center under pathogen-free
housing conditions.
Mp Infection in Mice
Strain FH (15531; ATCC, Manassas, VA) of Mp was
prepared as described previously.24e26 Muc18þ/þ and
Muc18/ mice (8 to 12 weeks of age) were anesthetized by
intraperitoneal injection of ketamine (70 mg/kg) and xylazine
(10 mg/kg), and were intranasally inoculated with 50 mL of
saline solution or Mp at 1  108 colony-forming units (CFU)
per mouse. Mice were sacriﬁced at 4 and 24 hours after Mp
infection or saline treatment.
Mouse BAL and Lung Tissue Processing
Mice were euthanized by intraperitoneal injection of sodium
pentobarbital. The lungs were ﬁrst lavaged with 1 mL saline
solution. An aliquot of BAL (10 mL) was used for Mp culture,
as described previously.24,25,27,28 Cell-free BAL ﬂuid was
stored at 80C for cytokine analysis. BAL cell cytospin
slides were stained with a Diff-Quick stain kit (IMEB, San
Marcos, CA) for cell differential counts or ﬁxed in ice-cold
acetone/methanol for MUC18 immunostaining. The lungs
were further lavaged four times by using 1 Hank’s balanced
salt solution supplemented with 0.5 mol/L EGTA for pAM
enrichment. Left lungs were homogenized to quantify Mp
levels by culture, as described previously.24,25,27,28
Mouse pAM Culture
BAL cells were collected, spun down, suspended in RPMI
1640mediumwith 10% fetal bovine serum, and seeded in 48-
well culture plates (4 104 cells per well) for 2 hours to allow
cells to adhere to cell culture plates. Thereafter, nonadherent
cells were removed. Adherent cells were then incubated with
or without Mp or the TLR2 agonist Pam2CSK4 (10 ng/mL;
InvivoGen, San Diego, CA) for 4 or 24 hours.
Adenovirus-Mediated MUC18 Gene Transfer in
Muc18/ Mouse pAMs
The pAMs from Muc18/ mice were enriched by adhering
BAL cells to 48-well culture plates (1 105 cells per well) for
2 hours; pAMs were then infected with replication-deﬁcient
type 5 adenoviruseexpressing mouse MUC18 cDNA
(AdMUC18) (Open Biosystems; Thermo Scientiﬁc, Hunts-
ville, AL) or an empty vector (AdControl) at multiplicity of
infection (MOI) Z 50 for 2 hours. Cells were then washedajp.amjpathol.org - The American Journal of Pathology
Table 1 Clinicodemographic Characteristics of Study Subjects
Condition Sample size Age (years) Sex (M/F) Smoking [pack-yr (no.)] FEV1 (% predicted) FVC (% predicted) FEV1/FVC
Normal n Z 4 52.3  4.3 2/2 0 (4) NA NA NA
COPD n Z 4 63.3  3.2 2/2 45.8  11.0 (4) 67.0  12.3 87.5  4.4 58.3  10.1
Asthma n Z 4 52.3  7.2 3/1 0 (3), 10 (1) 86.5  16.6 90.5  11.8 73.0  6.1
Data are expressed as means  SEM.
F, female; M, male; FVC, forced vital capacity; FEV1, forced expiratory volume in the ﬁrst second; NA, not available.
Normal COPD Asthma 
AM 
AM 
AM 
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Figure 1 MUC18 expression by human alveolar macrophages. A: MUC18
mRNAexpression in isolatedalveolarmacrophages fromhealthy subjects (nZ4)
and from patients with COPD (nZ 4) or asthma (nZ 4). Comparedwith healthy
subjects, the COPD and asthma patients exhibited higher levels of MUC18 mRNA
expression in alveolar macrophages. B: Representative MUC18 protein immu-
nostaining in human lung tissues. In contrast to alveolar macrophages (arrows)
in healthy lung, the alveolar macrophages in COPD and asthma patients had
increased MUC18 protein (purple) expression. Data are expressed as means 
SEM. Original magniﬁcation,400. AM, alveolar macrophage; BV, blood vessel.
MUC18 Ampliﬁes Lung Inﬂammationtwice to remove free adenovirus. At 48 hours after infection,
cells were used for i) Western blotting, to conﬁrm MUC18
expression after gene transfer; ii) treatment with or without
Pam2CSK4 (10 ng/mL) for 24 hours, to examine cytokineKC
production; or iii) pretreatment with the selective NF-kB
inhibitor helenalin (0.1 mmol/L; Sigma-Aldrich, St. Louis,
MO) for 1 hour, followed by stimulationwith Pam2CSK4 (10
ng/mL) for 4 hours, to measure KC production.
ELISA
KC and TNF-a levels in mouse BAL ﬂuid or macrophage
culture supernatants were determined by using the respec-
tive mouse KC or TNF-a enzyme-linked immunosorbent
assay (ELISA) DuoSet development kit (R&D Systems,
Minneapolis, MN). NF-kB p65 activity in mouse alveolar
macrophage nuclear proteins was measured by an ELISA-
based TransAM NF-kB p65 activation assay (Active Motif,
Carlsbad, CA).
Quantitative Real-Time RT-PCR
TaqMan gene expression assays for human MUC18
(Hs00174838_m1) and formouseMUC18 (Mm00522397_m1)
were obtained from Applied Biosystems (Life Technologies,
Foster City, CA). Quantitative real-time PCR was performed
on a CFX96 real-time detection system (Bio-Rad Laboratories,
Hercules, CA). The housekeeping geneGAPDHwas evaluated
as an internal positive control to normalize MUC18 expression.
The comparative threshold cycle method (DDCT) was used to
demonstrate relative MUC18 mRNA levels.27,29
Statistical Analysis
Data are presented as means  SEM. One-way analysis of
variance was used for multiple comparisons, and a Tukey’s
post hoc test was applied where appropriate. Student’s t-test
was used when only two groups were compared. P < 0.05
was considered signiﬁcant.
Results
MUC18 Expression in Human Alveolar Macrophages
Alveolar macrophages isolated from BAL cells of normal
healthy subjects and of patients with COPD or asthma were
examined for MUC18 expression. Patient characteristics are
summarized in Table 1. For both COPD and asthma patients,The American Journal of Pathology - ajp.amjpathol.orgMUC18 mRNA levels in alveolar macrophages were
increased, comparedwith those inhealthy subjects (Figure1A).
We used immunostaining to examine MUC18 protein
expression in alveolar macrophages of lung tissue sections
from four healthy donors, ﬁve COPD patients, and one patient
who died of asthma. Alveolar macrophages in healthy lung
tissue expressed minimal MUC18 (Figure 1B); however,
MUC18 protein was markedly increased in alveolar macro-
phages of COPD and asthmatic lungs.
Mouse Primary Alveolar Macrophages Express MUC18
We performed MUC18 protein immunostaining on BAL
cell cytospin slides from Muc18þ/þ and Muc18/ mice. No
MUC18 staining was seen in any BAL cells of Muc18/
mice (Figure 2A). In contrast, alveolar macrophages from
Muc18þ/þmice exhibited positive MUC18 staining. MUC18
protein localization to macrophages was further conﬁrmed
by double immunoﬂuorescent staining of MUC18 and F4/80
(a speciﬁc marker of mouse macrophages) (Figure 2B).
MUC18 protein expression in isolated alveolar macrophages
of Muc18þ/þ mice was conﬁrmed by Western blotting
(Figure 2C). We also veriﬁed MUC18 mRNA expression821
Figure 2 MUC18 expression by mouse alveolar macrophages. A: Alve-
olar macrophages of WT mice (Muc18þ/þ), but not Muc18 knockout mice
(Muc18/), stain positive for MUC18 (arrows). B: Double immunoﬂuo-
rescent staining of MUC18 (green) and F4/80 (red) demonstrates MUC18
localization to alveolar macrophages from Muc18þ/þ mice (arrows). C:
Western blot shows MUC18 protein in alveolar macrophages of Muc18þ/þ,
but not Muc18/ mice. Original magniﬁcation, 400.
Wu et alin isolated alveolar macrophages from Muc18þ/þ but not
Muc18/ mice (data not shown).
Modulation of Mp Infection-Induced Lung
Inﬂammation by MUC18
To examine the in vivo function of MUC18, Muc18þ/þ and
Muc18/ mice were inoculated with Mp or saline solution
for 4 and 24 hours, to quantify leukocytes and lung the
proinﬂammatory cytokines KC and TNF-a.822At 4 hours, compared with the saline control, Mp infection
increased KC levels in BAL ﬂuid and lung tissues of both
Muc18þ/þ andMuc18/mice (Figure 3, A and B); however,
the postinfection KC levels of Muc18/ mice were signiﬁ-
cantly lower (P < 0.05) than in Muc18þ/þ mice. KC levels
at 24 hours after Mp infection were signiﬁcantly lower (up to
20-fold), compared with those at 4 hours, in both groups
of mice. Thus, the KC differences observed at 4 hours
between Muc18þ/þ and Muc18/ mice had disappeared
after 24 hours of Mp infection. We then compared BAL
neutrophils in Mp-infected Muc18þ/þ and Muc18/ mice.
BAL neutrophils at 4 hours tended to be lower in Mp-infected
Muc18/ mice than in Muc18þ/þ mice (Figure 3C), but the
trend did not reach signiﬁcance (PZ 0.06).
We also measured TNF-a levels in BAL ﬂuid, because
TNF-a is one of the major cytokines from macrophages that
are commonly up-regulated during bacterial infection.
TNF-a was increased at 4 hours in Mp-infected Muc18þ/þ
and Muc18/ mice, compared with saline-treated mice
(Figure 3D). At 24 hours, however, TNF-a levels in BAL
ﬂuid were undetectable in both strains of mice.
Lung Mp Load in Muc18þ/þ and Muc18/ Mice
In contrast to the lung proinﬂammatory cytokine ﬁndings,
the bacterial load (ie, Mp load) was similar in lung tissue and
in BAL of Muc18þ/þ and Muc18/ mice at both 4 and 24
hours after Mp infection (Figure 4).
Reduced Cytokine Production in Muc18/ Mouse
Alveolar Macrophages
To determine whether MUC18 deﬁciency in alveolar mac-
rophages contributes to the reduction of proinﬂammatoryFigure 3 Proinﬂammatory cytokines and neu-
trophils in mouse lungs. Muc18þ/þ and Muc18/
micewere intranasally inoculatedwith saline solution
(control) or with Mp at 1 108 CFU per mouse. After 4
hours of infection, KC levels in BAL ﬂuid (A) and lung
tissue (B) were signiﬁcantly lower in Muc18/ mice
than in Muc18þ/þ mice. Moreover, levels of neutro-
phils (C) and TNF-a (D) in BAL ﬂuid ofMuc18/mice
were lower than in Muc18þ/þ mice. Data are
expressed as means  SEM. n Z 5 to 8 mice per
group. *P < 0.05.
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Figure 4 Mp load in lung tissue and BAL. Muc18þ/þ and Muc18/
mice were intranasally inoculated with Mp at 1  108 CFU per mouse. After
4 hours (A) and 24 hours (B) of infection, Mp levels were quantiﬁed in
entire left lungs and in BAL. Data are expressed as means  SEM. nZ 5 to
8 mice per group.
Figure 5 Reduced KC production in ex vivo Muc18/ alveolar
macrophages. Alveolar macrophages were isolated from Muc18þ/þ and
Muc18/ mice that were intranasally infected with Mp at 1  108 CFU
per mouse for 4 or 24 hours. Cells were incubated for 24 hours without
further stimulation. Data are expressed as means  SEM. n Z 3 repli-
cates. *P < 0.05.
MUC18 Ampliﬁes Lung Inﬂammationcytokines (KC, in particular) in Muc18/ mouse lungs
after Mp infection, we isolated alveolar macrophages from
Mp-infected Muc18þ/þ and Muc18/ mice and cultured
them for 24 hours in the absence of Mp. KC levels in
supernatants of alveolar macrophages from Mp-infected
Muc18/ mice sacriﬁced at 4 hours were twofold lower
than those from Muc18þ/þ mice (P < 0.05) (Figure 5).
However, cells from Mp-infected mice of both strains
sacriﬁced at 24 hours did not show signiﬁcant differences
in KC production. Thus, the ex vivo alveolar macrophage
KC data were supportive of the BAL ﬂuid data. TNF-
a levels in supernatants of alveolar macrophages collected
from Mp-infected Muc18þ/þ and Muc18/ mice sacri-
ﬁced at 4 and 24 hours were undetectable. These results
are in accord with our previous report that, unlike intra-
cellular pathogens, the extracellular pathogen Mp increases
lung inﬂammation mainly by increasing other proin-
ﬂammatory cytokines (eg, KC) rather than TNF-a.28
We then isolated alveolar macrophages from Mp-naïve
Muc18þ/þ andMuc18/mice, to further conﬁrm thatMUC18
in macrophage promotes KC production after Mp infection.
BecauseMp initiates inﬂammatory responsesmainly viaTLR2
signaling,25 we also stimulated the cells with the TLR2 agonist
Pam2CSK4, to test whether MUC18 interacts with TLR2
signaling. In accord with our ex vivo KC data in alveolar
macrophages fromMp-infected mice,Muc18/ cells in vitro
produced less KC after Mp infection or Pam2CSK4 stimula-
tion, compared withMuc18þ/þ cells (Figure 6, A and B).The American Journal of Pathology - ajp.amjpathol.orgMUC18 Reconstitution in Muc18/ Mouse Alveolar
Macrophages Enhances TLR2 Agonist-Induced
Proinﬂammatory Cytokine Production
Having shown thatMuc18 deﬁciency reduces KC production
in vivo and in vitro, we then examined whether restoring
MUC18 expression in Muc18/ mouse alveolar macro-
phages can reinstate proinﬂammatory responses to a TLR2
agonist. Primary Muc18/ alveolar macrophages treated
with an adenoviral vector encoding MUC18 cDNA or
an empty vector were treated with or without Pam2CSK4.
In the absence of Pam2CSK4 stimulation,AdMUC18 (but not
AdControl) inMuc18/ mouse pAMs successfully induced
MUC18 protein (Figure 7A). Notably,MUC18 reconstitution
in Muc18/ alveolar macrophages signiﬁcantly enhanced
KC production after TLR2 stimulation (Figure 7B).
NF-kB Activation Contributes to MUC18-Mediated
Proinﬂammatory Cytokine Production in Mouse
Alveolar Macrophages
Our data strongly suggest a proinﬂammatory role ofMUC18 in
alveolar macrophages, but the underlying mechanisms remain
largely unknown. Production of various proinﬂammatory
cytokines (including KC) depends on NF-kB activation after
various stimulants in macrophages.30e32 First, we examined
NF-kB p65 activity in isolated alveolar macrophages from
Muc18þ/þ and Muc18/ mice. After TLR2 stimulation,
Muc18/ pAMs showed lower NF-kB activation levels than
Muc18þ/þ pAMs (Figure 8A). Second, to prove the contribu-
tion ofNF-kBactivation toMUC18-mediated proinﬂammatory
cytokine production, Muc18/ pAMs with adenovirus-
mediated MUC18 reconstitution were stimulated with
Pam2CSK4 in the absence or presence of the selective NF-kB
inhibitor helenalin. Indeed,MUC18-mediated increase ofKC at
4 hours after TLR2 stimulation was signiﬁcantly inhibited by
helenalin (Figure 8B). Taken together, our data suggest that
MUC18-mediated proinﬂammatory effects are due in part to
activation of NF-kB pathway.823
Figure 6 Reduced KC production in in vitro Muc18/ alveolar macro-
phages. Alveolar macrophages from Mp-naïve Muc18þ/þ and Muc18/
mice were isolated and treated with medium (), Mp (MOI Z 1), or
Pam2CSK4 (Pam2; 10 ng/mL) for 24 hours. Data are expressed as means 
SEM. n Z 4 replicates. *P < 0.05.
Figure 7 Adenovirus-mediated MUC18 gene transfer in Muc18/
mouse alveolar macrophages resulted in MUC18 protein expression (A) and
in ampliﬁed KC production after stimulation for 24 hours with the TLR2
agonist Pam2CSK4 (10 ng/mL) (B). Data are expressed as means  SEM.
n Z 3 replicates. *P < 0.05. AdControl, control adenovirus; AdMUC18,
adenovirus-expressing mouse MUC18.
Wu et alDiscussion
To our knowledge, this is the ﬁrst study to reveal the function
of MUC18 in the lung. We discovered that alveolar macro-
phages in COPD and asthma lungs increase MUC18
expression. By using the Muc18 knockout mouse model, we
clearly demonstrated a critical role of MUC18 in promoting
early lung inﬂammatory responses to bacteria. Our data
suggest that up-regulated MUC18 expression in alveolar
macrophages in diseased lungs may contribute to the exces-
sive inﬂammatory responses to bacteria during acute exac-
erbations of the disease.
Acute exacerbations of COPD and asthma pose the highest
risks to patients (including death), and also the greatest costs
for disease-related health care.33 It is imperative to uncover
the mechanisms and ﬁndmore effective therapies to attenuate
disease exacerbations and progression.We ﬁrst demonstrated
MUC18 up-regulation in alveolar macrophages of COPD and
asthma patients. This ﬁnding is in accord with previous
reports of increased MUC18 levels in airway epithelial cells
from COPD and asthma patients.18,19
The present study is novel for exploration of MUC18
function in the lung in health and disease. Previous studies in
MUC18 have focused on its role in tumor growth and
metastasis, because MUC18 overexpression has been
observed in several types of tumors, including melanoma and
prostate cancer.12e14,34 Normally, MUC18 is expressed in
vascular endothelial cells and smoothmuscle cells, where it is
proposed to promote cellecell adhesions. In the present
study, alveolar macrophages in healthy humans expressed824negligible MUC18; however, MUC18 expression in alveolar
macrophages of COPD and asthma patients was signiﬁcantly
up-regulated.
In the present study, we focused on the function of MUC18
in lung inﬂammation, but did not address how MUC18 in
alveolar macrophages of asthma or COPD patients is up-
regulated. In our previous studies in human airway epithelial
cells, the Th2 cytokine IL-13 increasedMUC18 expression.18
In a preliminary study, we stimulated alveolar macrophages
from a nonsmoking healthy human subject with IL-13
(10 ng/mL), and observed a 3.5-fold increase of MUC18
mRNA. A similar result was also seen in IL-13-stimulated
alveolar macrophages (1.7-fold increase of MUC18 mRNA)
of wild-type (WT)mice. Additionally, our preliminary studies
suggested that exposure to cigarette smoke (as opposed to
ordinary air) increasedMUC18mRNA expression 4.1-fold in
cultured healthy human alveolar macrophages. Future studies
are needed to conﬁrm our preliminary data, and to deﬁne the
underlying molecular mechanisms of MUC18 up-regulation
in alveolar macrophages of COPD and asthma patients.
The major strength of the present study is to reveal the
proinﬂammatory function of MUC18 during lung bacterial
infection. First, we used theMuc18 knockout mouse model to
demonstrate that lack of MUC18 reduces production of the
proinﬂammatory cytokines KC and TNF-a and reduces
neutrophil recruitment into the lung soon after Mp infection
(at 4 hours). After 24 hours of bacterial infection, however,
MUC18 no longer appears to play a major role in lung
inﬂammation (likely because lung inﬂammation is regulatedajp.amjpathol.org - The American Journal of Pathology
Figure 8 Role of NF-kB in MUC18-mediated KC production in mouse
alveolar macrophages. A: Muc18/ alveolar macrophages exhibit less
nuclear NF-kB p65 activation than Muc18þ/þ alveolar macrophages after
30 minutes of stimulation with the TLR2 agonist Pam2CSK4 (10 ng/mL). B:
KC induction (4 hours) in Pam2CSK4-stimulated Muc18/ alveolar
macrophages with adenovirus-mediated MUC18 gene transfer is inhibited
by the selective NF-kB inhibitor helenalin. Data are expressed as means 
SEM. n Z 3 replicates. *P < 0.05. DMSO, dimethyl sulfoxide; OD, optical
density.
Figure 9 Proinﬂammatory cytokine KC in mouse BAL ﬂuid. Muc18þ/þ
and Muc18/ mice were intranasally inoculated with saline solution
(control) or nontypeable Haemophilus inﬂuenzae (NTHi) at 1  107 CFU per
mouse. After 4 hours of infection, BAL ﬂuid was collected for ELISA
measurement of KC levels. Data are expressed as means  SEM. nZ 3 or 4
mice per group. *P < 0.05.
MUC18 Ampliﬁes Lung Inﬂammationby multiple factors). Taken together, our in vivo data strongly
suggest a proinﬂammatory function of MUC18 during acute
exacerbations of the disease. Although Muc18/ mice had
lower levels of proinﬂammatory cytokines than theWTmice,
lung bacterial Mp load was similar in the two strains of mice.
Previous studies also demonstrated inconsistency between
inﬂammation and lung bacterial load.35,36 An appropriate
inﬂammatory response is known to be critical to maintaining
host defense against infection. The fact that Muc18/ mice
have lower levels of proinﬂammatory cytokines than do WT
mice, but have similar lung bacterial loads, suggests that
blocking up-regulated MUC18 in asthma and COPD patients
may reduce excessive inﬂammation without impairing lung
defenses against bacteria.
To deﬁne howMUC18 promotes inﬂammatory responses,
we focused on alveolar macrophages, because of their role in
exaggerated inﬂammatory responses to invading pathogens
during COPD and asthma exacerbations. To clearly illustrate
the role of MUC18, we isolated alveolar macrophages
from Muc18 knockout and WT mice. Cytokine inductionThe American Journal of Pathology - ajp.amjpathol.orgdecreased in MUC18-deﬁcient alveolar macrophages after
Mp infection or stimulation with a TLR2 agonist, compared
with MUC18-sufﬁcient alveolar macrophages. Conversely,
when MUC18-deﬁcient macrophages were transduced with
MUC18 cDNA, cytokine production increased. Taken
together, our data suggest that MUC18 in alveolar macro-
phages serves as one of the major mechanisms to enhance
lung inﬂammatory responses to bacteria (eg, Mp).
HowMUC18 signals in cells such as macrophages remains
a mystery. One could speculate that MUC18 serves as
a receptor for bacteria or bacterial components.We conducted
a preliminary study in which aMUC18mutant with truncated
extracellular domain was transiently transfected into THP-1
cell-derived macrophages. Compared with the WT MUC18
cDNA transfection, the MUC18 mutant did not reduce KC or
TNF-a production after stimulation with the TLR2 agonist
Pam2CSK4. Thus, theMUC18 extracellular domain does not
likely serve as a receptor for bacterial products such as TLR2
agonist. Future studies are needed to deﬁne how the MUC18
cytoplasmic tail interacts with inﬂammatory signaling path-
ways after bacterial infection or TLR agonist stimulation.
Because NF-kB is known to regulate various proin-
ﬂammatory cytokines at the transcriptional level, we examined
whether MUC18 promotes NF-kB activation. Indeed, NF-kB
activation levels were lower in MUC18-deﬁcient macrophages
than those in WT cells. Our NF-kB selective-inhibitor exper-
iments further conﬁrmed that MUC18-mediated proin-
ﬂammatory cytokine production occurs in part by enhancing
NF-kB activation. Although the NF-kB pathway is involved in
MUC18-mediated proinﬂammatory cytokine production, other
transcription factors may also be involved. Using an SABio-
sciences text mining application (Qiagen, Frederick, MD) and
the UCSC Genome Browser (http://www.genome.ucsc.edu),
we identiﬁed several putative transcription factor binding sites
in the promoter region of mouse KC gene in addition to NF-
kB, including Sp1. To examine whether Sp1 is indeed involved
in the proinﬂammatory function of MUC18, we isolated
alveolar macrophages from Muc18/ mice and reconstituted825
Wu et alMUC18 expression by using adenovirus-mediated gene
transfer. Thereafter, we stimulated the cells with Pam2CSK4 in
the absence or presence of 10 to 100 nmol/L of the Sp1
inhibitor mithramycin A (alias plicamycin), to determine
whether Sp1 directly contributes to MUC18-mediated KC
production. Adenovirus-mediated MUC18 gene transfer in
Muc18/ alveolar macrophages increased KC production
after Pam2CSK4 stimulation; however, MUC18-mediated KC
production was not altered by the Sp1 inhibitor. Taken
together, our data suggest that Sp1 does not likely play a role in
MUC18-mediated KC production in alveolar macrophages,
but that other transcription factors (eg, NF-kB) may be
important.
The present study has several limitations. First, prospective
studies in alveolar macrophages from normal human subjects
and from patients with COPD and asthma would be necessary
to deﬁne the dependence of bacteria-mediated inﬂammatory
responses on MUC18 expression levels. Second, the relative
contribution of MUC18 in alveolar macrophages versus other
lung cells (eg, airway epithelial cells) to lung inﬂammatory
responses against bacteria should be deﬁned (eg, by using
the mouse bone marrow chimera approach in Muc18þ/þ and
Muc18/ mice). Third, the molecular mechanisms by which
MUC18 promotes early (but not late) inﬂammation need to
be further deﬁned. Fourth, the present study mainly used
MUC18-deﬁcient mice or alveolar macrophages with
adenovirus-mediated MUC18 gene transfer to study MUC18
functions. We expect to consider other complementary
approaches in future studies, such as anti-MUC18 antibodies in
WT mice, to further deﬁne MUC18 functions during lung
bacterial infection. Finally, the present study used only the
mycoplasma infection model to determine MUC18 functions.
Further studies are necessary to clarify whether MUC18 is
involved in lung inﬂammatory responses to other strains
of respiratory bacteria. In a preliminary study, we infected
Muc18þ/þ and Muc18/ mice intranasally with nontypeable
Haemophilus inﬂuenzae, the most common bacterium seen
in COPD lungs (particularly during acute exacerbations). After
4 hours of infection, KC levels in BALF of Muc18/ were
signiﬁcantly lower than those in Muc18þ/þ mice (Figure 9).
We conclude, therefore, that MUC18 may regulate lung
inﬂammatory responses to a variety of respiratory pathogens.
In summary, the present pioneering study has revealed
a mechanism involving, MUC18 whereby alveolar macro-
phages in diseased lungs sensitize the host to bacteria-
mediated inﬂammatory responses to invading pathogens.
This understanding of the role of MUC18 in exaggerating
lung inﬂammation suggests potential therapeutic options.References
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